Clinical guidelines for the treatment of depressive disorders VII. Comorbidity
MW Enns, JR Swenson, RS McIntyre… - The Canadian …, 2001 - journals.sagepub.com
Background: The Canadian Psychiatric Association and the Canadian Network for Mood
and Anxiety Treatments partnered to produce clinical guidelines for psychiatrists for the …
and Anxiety Treatments partnered to produce clinical guidelines for psychiatrists for the …
Emerging drugs for major depressive disorder
KR Connolly, ME Thase - Expert opinion on emerging drugs, 2012 - Taylor & Francis
Introduction: Major depressive disorder (MDD) remains a major public health concern, and
one that continues to suffer an incompletely-met need for effective and acceptable …
one that continues to suffer an incompletely-met need for effective and acceptable …
Pharmacological approaches to manage persistent symptoms of major depressive disorder: rationale and therapeutic strategies
I Epstein, I Szpindel, MA Katzman - Psychiatry research, 2014 - Elsevier
Major depressive disorder (MDD) is a highly prevalent chronic psychiatric illness associated
with significant morbidity, mortality, loss of productivity, and diminished quality of life …
with significant morbidity, mortality, loss of productivity, and diminished quality of life …
Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults.: III. Pharmacotherapy
BACKGROUND: In 2001, the Canadian Psychiatric Association and the Canadian Network
for Mood and Anxiety Treatments (CANMAT) partnered to produce evidence-based clinical …
for Mood and Anxiety Treatments (CANMAT) partnered to produce evidence-based clinical …
[HTML][HTML] Relative efficacy and acceptability of antidepressant drugs in adults with major depressive disorder: commentary on a network meta-analysis
C Andrade - The Journal of Clinical Psychiatry, 2018 - psychiatrist.com
ABSTRACT A large number of antidepressant drugs are available across the world. All have
been compared against placebo, and many have been compared with some but not all other …
been compared against placebo, and many have been compared with some but not all other …
Antidepressants versus placebo in major depression: an overview
A Khan, WA Brown - World Psychiatry, 2015 - Wiley Online Library
Although the early antidepressant trials which included severely ill and hospitalized patients
showed substantial drug‐placebo differences, these robust differences have not held up in …
showed substantial drug‐placebo differences, these robust differences have not held up in …
Clinical guidelines for the treatment of depressive disorders III. Psychotherapy
Background: The Canadian Psychiatric Association and the Canadian Network for Mood
and Anxiety Treatments partnered to produce clinical guidelines for psychiatrists for the …
and Anxiety Treatments partnered to produce clinical guidelines for psychiatrists for the …
Depressive disorders: Treatment failures and poor prognosis over the last 50 years
TP Blackburn - Pharmacology research & perspectives, 2019 - Wiley Online Library
Depression like many diseases is pleiotropic but unlike cancer and Alzheimer's disease for
example, is still largely stigmatized and falls into the dark shadows of human illness. The …
example, is still largely stigmatized and falls into the dark shadows of human illness. The …
[HTML][HTML] Терапия тяжелой рекуррентной депрессии
ЕЮ Антохин - Психиатрия и психофармакотерапия, 2010 - medi.ru
Рекуррентная депрессия (РД) является распространенным заболеванием, которое
встречается у 15-25% женщин и 6-12% мужчин [1-3]. Часто у больных РД возникают …
встречается у 15-25% женщин и 6-12% мужчин [1-3]. Часто у больных РД возникают …